Brief: Daré Bioscience Announces Start Of A Phase 1 Study For Its Potential First-In-Category Treatment For Primary Dysmenorrhea, Dare-Pdm1

Dare Bioscience

22/02/2023 13:28

Feb 22 (Reuters) - Dare Bioscience Inc  DARE.O :
    * DARÉ BIOSCIENCE ANNOUNCES START OF A PHASE 1 STUDY FOR ITS
POTENTIAL FIRST-IN-CATEGORY TREATMENT FOR PRIMARY DYSMENORRHEA,
DARE-PDM1

Source text for Eikon:  ID:nGNXbXYlgg 
Further company coverage:  DARE.O